Epilepsy is a condition which spans several disciplines within medicine, as well as having an impact on many non-medical areas such as employment and education. Services for epilepsy in the UK have not been developed according to any coherent strategy and remain fragmented and unevenly distributed. Successive attempts to address these shortcomings by publishing recommendations, even with government assistance, have not led to major improvements. Recent changes in the organization of health care services might at least present an opportunity to effect change by educational initiatives directed towards purchasers and providers. However, the absence of epilepsy from The Health of the Nation objectives represents a failure to get the message through to those with the ability to direct policy. The plethora of new, effective and expensive pharmaceutical treatments should lead to a raising of epilepsy awareness among the medical profession as a consequence of marketing activity, but this is already causing conflict with Family Health Service Associations (FHSAs) and others with equivalent lack of vision. I would suggest that only by politicizing the consumer can the change we seek be brought about.
Epilepsy is a common condition, with a point prevalence of about 1% and a lifetime prevalence of over 3% in developed countries. It is about 10 times more common than multiple sclerosis, and 100 times more common than motor neurone disease. An 'average' general practitioner in the UK will care for at least 10 patients on active treatment and will have up to 25 more patients with a history of seizure. The US Commission on control of Epilepsy and Its Consequences in 19781 divided epilepsy needs into five groups. The prevalence of the different groups as estimated is given in Fig. 1 .
Group 4 (2600) Since that time, attitudes towards residential care have changed, and it is probably appropriate to consider these figures as reflecting particular degrees of care need which still need to be met, whether in the community or institutionally. More recently, Shorvon 2 has described the prevalence of some associated People per million factors which influence care needs. Even excluding the equivalents of the US Groups 1 and 5, he suggests that 1600 people per million have epilepsy complicated by learning disability, and 1800 have additional psychiatric morbidity, with only 350 presenting additional neurological problems (Fig. 2 ). These figures have consequences for the necessary training of any specialist working in the field of epilepsy, in particular the training of neurologists. The naive view that the answer to the shortfall in services is to train more neurologists should be qualified by a consideration of what that training should involve.
Most people with epilepsy have tonic-clonic seizures, whether primary or secondarily generalized (Fig. 3 ). This seizure type may be com-
Tonic-clonic and partial 13%
Tonic-clonic only 66% plicated by head injury and hypoxia. Other common seizure types such as complex partial seizures may also put the patient into potentially dangerous situations. From these dangers arise both physical complications due to injury, and psychosocial disadvantage due to overprotection and fear of venturing out. Thus management has to involve more than mere medical treatment of seizure threshold, and becomes a multidisciplinary, multiagency affair with ramifications into the fields of employment, education and family life. Areas of overlap between disciples may lead to some issues being unattended to unless an integrated approach can be achieved. There is a relationship between seizures and the emotional climate of the family. In one study 3 high expressed emotion (criticism, hostility and emotional over-involvement directed by one family member to another) was uniquely observed in families where a member continued to have seizures. This may demonstrate a potential for a family-based approach to treatment. Epilepsy also carries a significant mortality, up to four times that of the population without epilepsy and this excess is greatest in the young. It is highest in the first 10 years after diagnosis and the commonest cause is sudden unexpected death (SUDEP), with accidents and suicide also being significant causes.
Epilepsy is therefore a common and potentially serious condition with a significant morbidity and mortality.
HOW CAN WE ORGANIZE ECONOMICALLY VIABLE SERVICES ACCESSIBLE TO ALL?
There have been various recommendations over the years, including the reports of Reid 4 and Winterton 5. In all honesty we have to admit that these have had little impact. Ser-vices for epilepsy in the UK continues to be uncoordinated and patchy, with a significant part of the provision coming from the voluntary or charitable sector, or else driven by 'soft money' reflecting the personal enthusiasm of a few specialists. More recently some of us have made an attempt to influence policy with the 'Epilepsy Needs Document '8. We await the outcome. The task ahead includes: (1) setting a plan for change which is acceptable to consumers and feasible to professionals, and (2) demonstrating the effectiveness of development and expansion of services to those who allocate resources. The plethora of new (and expensive) pharmaceutical treatments in epilepsy has brought an increase in industrysponsored medical education initiatives. In the present climate this is all to the good.
SERVICE NEEDS
Recent changes in the organization of health care services might at least present an opportunity to effect change by educational initiatives directed towards purchasers and providers. However, the absence of epilepsy from The Health of the Nation objectives 7 represents a failure to get the message through to those with the ability to direct policy. Cost improvement exercises at the FHSA level have promoted generic substitution as acceptable practice. However, there is evidence that this can have dangerous consequences for some people with epilepsy s. The British Epilepsy Association, in a survey of nearly 2000 people with epilepsy, identified significant and wideranging problems in daily life. More than 70% of respondents considered medication to be a problem, and a similar number identified problems in employment, self image and social life 9. Educational Statements intended to assist appropriate provision for children with special needs are frequently inadequate and insufficient to help those with complex epilepsy 1°. Developments in service provision should be sensitive to these deficiencies and attempt to correct them.
In the 'Epilepsy Needs Document' we attempted to quantify epilepsy needs and set what we considered to be reasonably achievable standards. It is, of course, already out of date. The process of initiating and leading changes has itself to be ongoing and responsive to feedback.
ACHIEVING CHANGE
There are over 20 charities concerned with epilepsy in the UK, ranging from predominantly patient-led groups such as the British Epilepsy Association, to care providers such as the National Society for Epilepsy or the David Lewis Centre, Cheshire. These come together as a confederation under the umbrella of the Joint Epilepsy Council (JEC). Professionals in the epilepsy world meet through the British Chapter of the International League Against Epilepsy (ILAE). There is an opportunity now for these two bodies to set a joint agenda for action. This must include at the very least the following.
1. Ensuring a minimum standard of education about epilepsy needs among health purchasers, including FHSA medical advisors, particularly regarding potential pitfalls with generic substitution of antiepileptic drugs, health economic benefits of new therapies, and health economic benefits of epilepsy surgery. 2. Setting minimum standards within the education system for identifying and dealing with special educational aspects of epilepsy. 3. Raising awareness among consumers (patients and their families) of the potential for improvement in epilepsy care and treatment. 4. Maintaining a dialogue with the government covering the areas of health, education and social policy.
Some academic activity might also be usefully directed toward assessing health economic aspects of epilepsy care.
Working towards change in this way, with patients, their families and the professionals operating as a team, represents a move away from tradii~ional doctor-centred medicine. The more traditional approach is likely to fail due to insensitivity to needs and slowness to adapt to change, combined with powerlessness in the face of changes in social policy. Only by politicizing the consumer can the change we seek be brought about.
